Research & Development: Page 65
-
PharmaVoice Team/PharmaVoice
Last Word
Taking Innovation to a New Level Ulrich Betz, Ph.D., Director at Merck Serono Portfolio Development and Head of the Department Center of Innovation, talks about fostering innovation and entrepreneurial thinking within the company. PV: What is the Merck Serono internal Innospire innovation program...
By Ulrich Betz • Sept. 27, 2011 -
PharmaVoice Team/PharmaVoice
Pharma Trax
Sales, marketing, And R&D?Trends affecting the healthcare industry Vision and Planning are Key to Efficient Real-World Data Use Trend: Market forces are driving the need for real-world data in the life-sciences industry. Recommendations for Real-World Data Research » Develop a shared vision...
By PharmaVoice Team • Sept. 27, 2011 -
Explore the Trendline➔
Stock via Getty Images
TrendlineArtificial intelligence & machine learning
After years of excited buzz around the potential of artificial intelligence and machine learning, pharma has begun to realize the true implications and potential value of these technologies.
By PharmaVoice staff -
PharmaVoice Team/PharmaVoice
Tools of the Trade
New electronic and web-based applications, sites, and technologies POR Provides Real-Time Engagement Between Doctors and Brands Trend: Driven by physician access issues and shrinking sales forces, pharma brand marketers are looking for ways to use nonpersonal and digital promotion more effectivel...
By PharmaVoice Team • Sept. 27, 2011 -
PharmaVoice Team/PharmaVoice
What's New
New healthcare-related products, services, and companies Lumina Seeks to Support Medical Affairs Teams Trend: Pharma and biotech medical affairs organizations are playing an increasingly critical role in addressing the information needs of healthcare professionals and patients. KnowledgePoint360 ...
By PharmaVoice Team • Sept. 27, 2011 -
PharmaVoice Team/PharmaVoice
Outlet
Opinions, insights, and commentary from around the industry Getting to Variable Costs: Regulated Cloud-Sourcing Emerges Chuck Saldarini, CEO of Sentrx Safety Solutions, is redefining the standard for safety services by putting best practices into action, developing innovative solutions founded o...
By Chuck Saldarini • Sept. 27, 2011 -
PharmaVoice Team/PharmaVoice
The Impact of an Integrated Execution Environment on Data Management in Adaptive Clinical Trials
Contributed By Corey B. Dunham, VP Data Management and Statistics, North America Anyone who has baked a cake can tell you that the quality of the ingredients is equally as important as following the recipe. Data quality in clinical trials is much the same way. You can follow the protocol and stan...
By Corey B. Dunham • Aug. 29, 2011 -
PharmaVoice Team/PharmaVoice
Decoding Data Dynamics
By Carolyn Gretton The shift in life-sciences development toward more personalized therapeutics is driving a need for proactive clinical data management (CDM) strategies that take into account the volume and complexity of information emerging from today’s clinical trials. Data management is being...
By Carolyn Gretton • Aug. 29, 2011 -
PharmaVoice Team/PharmaVoice
Hola Mexico: Pharma Drawn to U.S. Neighbor
By Kim Ribbin Growing health coverage, high medical standards, a motivated patient population, and huge geographic advantages make Mexico an appealing market for the pharmaceutical industry. With a population of around 110 million people and a growing focus on healthcare, Mexico has fast becom...
By Kim Ribbink • Aug. 29, 2011 -
PharmaVoice Team/PharmaVoice
Beyond Stem Cells
By Denise Myshko It may seem like science fiction: a trachea grown from stem cells and implanted into a human being. But it’s not; this is an actual account of the power of stem cells and regenerative medicine. The 36-year-old patient, who had been suffering from late-stage tracheal cancer, recei...
By Denise Myshko • Aug. 29, 2011 -
PharmaVoice Team/PharmaVoice
Mentoring: More Crucial Than Ever
By Robin Robinson With the industry in constant flux, industry leaders say mentoring is key for career advancement. Declining budgets, the emergence of small innovative startups with fewer resources, busy schedules, and an ever-changing work environment are a few of the factors that make mentorin...
By Robin Robinson • Aug. 29, 2011 -
PharmaVoice Team/PharmaVoice
The New Frontier: Therapeutic Vaccines
By Denise Myshko Researchers continue to evaluate the sustainability of powering the immune system to treat cancers and other serious diseases. For years researchers have been trying to find a way to trigger the body’s immune system to recognize cancers and other diseases. Early attempts to use c...
By Denise Myshko • Aug. 29, 2011 -
PharmaVoice Team/PharmaVoice
Public Service: Improving Adherence
By Robin Robinson For the next three years, the National Consumer League and its 100 partners will focus on improving adherence for chronic diseases. With almost 75% of patients in the United States not taking medicine as prescribed by their doctors, the public awareness campaign, Script Your Fut...
By Robin Robinson • Aug. 29, 2011 -
PharmaVoice Team/PharmaVoice
PharmaTrax
Sales, marketing, And R&D Trends affecting the healthcare industry By Carolyn Gretton U.S. Prescription Drug Spending Posts Modest Increase for 2010 Trend: Fewer physician office visits and new therapy starts indicate that U.S. patients are scaling back their use of prescription medicines ami...
By Carolyn Gretton • Aug. 29, 2011 -
PharmaVoice Team/PharmaVoice
UpFront
UpFront Awards… » CSL Behring Receives NORD Award CSL Behring has received the National Organization for Rare Disorders (NORD) 2011 Corporate Award for new treatments brought to market for patients with rare diseases. CSL Behring’s new treatment, Factor XIII concentrate (human), is approved fo...
By PharmaVoice Team • Aug. 29, 2011 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
The New Market Frontier New segmentation techniques might just be the way to uncover the next growth opportunity for brands. Audience segmentation has been around forever and is used by most companies to identify those consumers who are the right fit for their brands — and companies are spending ...
By Taren Grom • Aug. 29, 2011 -
PharmaVoice Team/PharmaVoice
2011 PharmaVOICE 100 - Who's on the List by Section
The Commanders & Chiefs Frank Baldino Jr., Ph.D. Cephalon Inc. Donna Beardsworth. Beardsworth Group Calep A. (Joe) Boyd III MCS Healthcare Public Relations Randall Carpenter, M.D. Seaside Therapeutics N. Anthony Coles, M.D. Onyx Pharmaceuticals B. Reid Connolly evoke interaction Donna Cryer C...
By PharmaVoice Team • July 26, 2011 -
PharmaVoice Team/PharmaVoice
Talent Pool
Executive appointments and promotions in the healthcare industry By Carolyn Gretton Pharmaceutical POOL Damian BRAGA Sanofi Pasteur Consolidates Commercial Operations Leadership Sanofi Pasteur, the vaccines division of global healthcare company Sanofi, has tapped U.S. President Damian Braga as s...
By Carolyn Gretton • July 26, 2011 -
PharmaVoice Team/PharmaVoice
2011 PharmaVOICE 100 - Who's on the List by Company
Acorda Therapeutics Andrew Blight, Ph.D. ACT Biotech Inc. Ali Fattaey, Ph.D. Acucela Inc. Ryo Kubota, M.D., Ph.D. Alliance Healthcare Information LLC Mary Anne Greenberg Almac Group Sir Allen McClay The Avoca Group Inc. Patricia Leuchten AXON US Mario Nacinovich Beardsworth Group Donna Beardswort...
By PharmaVoice Team • July 26, 2011 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
Taking Inspiration to the Next Level This is our favorite issue of the year, and we hope it’s yours too. It has been a joy and a privilege to have had a chance to get to know this year’s PharmaVOICE 100. They certainly illustrate what it means to think bigger, do more, and lead with passion and i...
By Taren Grom • July 26, 2011 -
PharmaVoice Team/PharmaVoice
Managing Outsourced Development: Designing a Performing Process
Ronald S. Waife, MPH, President With the rise of mega-CROs, and the widespread willingness of large pharma to outsource clinical development to them, is there anything left for a sponsor’s clinical development group to do? Indeed yes. More than ever, there are hyper-critical functions that sponso...
By Ronald S. Waife • May 25, 2011 -
PharmaVoice Team/PharmaVoice
Industry Experts Challenge the Status Quo on Content Management
For more than two decades, life sciences organizations have purchased, customized, configured, deployed, and maintained a series of ever-expanding and complex content management tools to help them efficiently manage content. The creation of industry-specific applications added to these technologi...
By Ian Talmage • May 25, 2011 -
PharmaVoice Team/PharmaVoice
Clinical Data Gap Analysis Uncovering Hidden Opportunities
David Fishman, MBA President Snowfish LLC The practice of medicine relies on clinical evidence. From a product’s conception through approval, launch, and post-launch activities, clinical evidence is the rationale for a product’s overall existence. Clinical data is critical for differentiation and...
By David Fishman • May 25, 2011 -
PharmaVoice Team/PharmaVoice
Metrics for Faster Clinical Trials
Almost half of clinical trials run late, year after year. Why does this happen? The biggest delaying factor is finding enough patients, and the delay starts with the clinical trial protocol. The protocol includes the inclusion and exclusion criteria that define the patients who are eligible for t...
By Bill Gwinn • May 25, 2011 -
PharmaVoice Team/PharmaVoice
Bringing Process Efficiency to Clinical Trial Randomization
Modern business has fully embraced the benefits of process efficiency. From the widespread adoption of process improvement as driven by Michael Hammer, author of “Reengineering the Corporation," its evolution to the Six Sigma movement, to the more recent “lean sigma" approach, process efficiency ...
By PharmaVoice Team • May 25, 2011 -
PharmaVoice Team/PharmaVoice
Partnering with CROs: Achieving Operational Excellence
Our industry is facing a challenge. In 2010, the FDA approved only 21 new drugs, down from 26 in 2009 and 24 in 2008. To counteract this decrease, biopharmaceutical companies are increasingly anxious to launch their products as quickly as possible to benefit from related revenue sooner. One way t...
By PharmaVoice Team • May 25, 2011
Previous
